title: The efficacy of miRNA122, a novel therapeutic target, for predicting the progression of hepatocellular carcinoma (HCC).
authors: Research Center for Biological Therapy, The Institute of Translational Hepatology, Beijing 302 Hospital, Beijing, China.
authors: Lifeng
authors: L
authors: Wang
authors: Zheng
authors: Z
authors: Zhang
authors: Fu-Sheng
authors: FS
authors: Wang
mesh_terms: D000818:Animals; D014408:Biomarkers, Tumor / Q000235:genetics / Q000378:metabolism*; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology / Q000503:physiopathology; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D018450:Disease Progression; D015536:Down-Regulation; D015316:Genetic Therapy; D006801:Humans; D050356:Lipid Metabolism / Q000235:genetics; D008113:Liver Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000503:physiopathology; D035683:MicroRNAs / Q000235:genetics / Q000378:metabolism*; D009928:Organ Specificity; D057089:Pathology, Molecular / Q000639:trends; D011237:Predictive Value of Tests; D011379:Prognosis
chemical_list: D014408:Biomarkers, Tumor; C531907:MIRN122 microRNA, human; D035683:MicroRNAs